Our previous study demonstrated that in breast cancers, IL-6 stimulates STAT3-dependent, nuclear factor-κB-mediated indoleamine 2,3-dioxygenase (IDO) upregulation in MDSCs (7); this triggers immunosuppressive effects of MDSCs in vitro and vivo (6). The gene discussed is IL6; the disease is breast carcinoma.